ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,995.54
0.38%
US Tech 100
20,562.00
0.10%
Dow Jones
43,988.99
0.59%
Brent Oil
73.885
0.00%
Bitcoin
76,509.33
-0.08%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Indices
  4. FTSE
  5. FTSEurofirst 300 Pharmaceuticals and Biotechnology Index (E3X201030)

  6. FTSEurofirst 300 Pharmaceuticals and Biotechnology Index (E3X201030) Financials

E3X201030 FTSEurofirst 300 Pharmaceuticals and Biotechnology Index

3,052.71
24.37 (0.80%)
Nov 08 2024 - Closed
Delayed by 15 minutes
Company name:FTSEurofirst 300 Pharmaceuticals and Biotechnology Index
EPIC:E3X201030Trading Currency:GBP
Market Sector:ISIN:
Market Segment:Share Type:IX
WWW Address:Description:
Industry Sector:
 Price Price Change [%] Bid Ask Open High Low Volume
 3,052.71 images.advfn.com/imagesnew/2/us/up 24.37 [0.80] - - 3,028.34 3,076.45 3,028.34 -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 - - - - - - - 3,526.94 - 2,726.57

FTSEurofirst 300 Pharmac... Key Figures

(at previous day's close)
Market Cap.-m
Shares In Issue-m
Prev. Close3,028.34
PE Ratio- 
Dividend Yield-%
EPS - basic-p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-p
Return On Equity (ROE)-%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt-m
Gross Gearing-%
Quick Assets-m
Net Working Capital-m
Intangibles / Fixed Assets-%
Turnover PS-p
Pre-Tax Profit PS-p
Retained Profit PS-p
Cash PS-p
Net Cash PS-p
Net Tangible Asset Value PS *-p
Net Asset Value PS-p
Spread- (-%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

FTSEurofirst 300 Pharmac... Balance Sheet

Sorry No Data Available

Share Price Performance

Sample Period †HighLow
1 week3,172.013,012.21
4 weeks3,311.653,012.21
12 weeks3,526.943,012.21
1 year3,526.942,726.57

Share Price Chart (5 years)

FTSEurofirst 300 Pharmac... Historic Returns

Giorni da oggi †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week3,120.55-67.84-2.173,012.21--
4 weeks3,237.93-185.22-5.723,012.21--
12 weeks3,413.47-360.76-10.573,012.21--
26 weeks3,105.11-52.40-1.693,012.21--
1 year2,781.95270.769.732,726.57--
3 years2,624.97427.7416.302,457.70--
5 years90.232,962.483,283.2590.23--
† periods calculated are whole weeks rather than calendar months

FTSEurofirst 300 Pharmac... Key Management Ratios

FTSEurofirst 300 Pharmac... Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio - 
Tobin's Q Ratio (excl. intangibles)- 
Dividend Yield-%
Market-to-Book Ratio- 
Price-to-Pre-Tax Profit PS- 
Price-to-Retained Profit PS- 
Price-to-Cash Flow PS- 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS- 
Price-to-Cash PS- 
Net Working Capital PS- 
Price Pct to Working Capital PS-%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

FTSEurofirst 300 Pharmac... Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-%
Net Gearing (excl. Intangibles)-%
Gross Gearing-%
Gross Gearing (excl. Intangibles)-%
Gearing Under 1 Year-%
Gearing Under 1 Year (excl. Intgbl)-%
Assets/Equity- 
Cash/Equity- 
(Liquidity Ratios)
Net Working Capital to Total Assets-%
Current Ratio- 
Quick Ratio (Acid Test)- 
Liquidity Ratio- 
Cash & Equiv/Current Assets-%
(Solvency Ratios)
Enterprise Value-m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets- 
CFO/Debt- 
Total Debt/Equity Market Value- 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit- 
Total Debt-m
Total Debt/Net Current Assets-%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)
Sorry No Data AvailableSorry No Data Available

FTSEurofirst 300 Pharmac... Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-%
Return On Assets (ROA)-%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-%
Return On Investment (ROI)-%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

FTSEurofirst 300 Pharmac... Dividends

Sorry No Data Available

FTSEurofirst 300 Pharmac... Fundamentals
Sorry No Data Available

FTSEurofirst 300 Pharmac... Balance Sheet

Sorry No Data Available

FTSEurofirst 300 Pharmac... Cash Flow Statement

Sorry No Data Available

FTSEurofirst 300 Pharmac... Brokers

Broker infomation is not available for this class of share.

Your Recent History

FTSE
E3X201030
FTSEurofirst 300 Pharmac...
BIT
UB51N7
Unicredit Bank
NASDAQ
ZAPZTX
Female Founders Fund Iv
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved